| Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1 A Castegna, M Aksenov, M Aksenova, V Thongboonkerd, JB Klein, ... Free Radical Biology and Medicine 33 (4), 562-571, 2002 | 738 | 2002 |
| Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71 A Castegna, M Aksenov, V Thongboonkerd, JB Klein, WM Pierce, ... Journal of neurochemistry 82 (6), 1524-1532, 2002 | 727 | 2002 |
| Proteomic identification of nitrated proteins in Alzheimer's disease brain A Castegna, V Thongboonkerd, JB Klein, B Lynn, WR Markesbery, ... Journal of neurochemistry 85 (6), 1394-1401, 2003 | 686 | 2003 |
| Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease DM Good, P Zürbig, A Argiles, HW Bauer, G Behrens, JJ Coon, M Dakna, ... Molecular & cellular proteomics 9 (11), 2424-2437, 2010 | 579 | 2010 |
| Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation V Thongboonkerd, KR Mcleish, JM Arthur, JB Klein Kidney international 62 (4), 1461-1469, 2002 | 480 | 2002 |
| Clinical proteomics: a need to define the field and to begin to set adequate standards H Mischak, R Apweiler, RE Banks, M Conaway, J Coon, A Dominiczak, ... PROTEOMICS–Clinical Applications 1 (2), 148-156, 2007 | 361 | 2007 |
| Advances in urinary proteome analysis and biomarker discovery D Fliser, J Novak, V Thongboonkerd, V Jankowski, MA Girolami, ... Journal of the American Society of Nephrology 18 (4), 1057-1071, 2007 | 351 | 2007 |
| Recommendations for biomarker identification and qualification in clinical proteomics H Mischak, G Allmaier, R Apweiler, T Attwood, M Baumann, A Benigni, ... Science translational medicine 2 (46), 46ps42-46ps42, 2010 | 340 | 2010 |
| Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes X Shen, S Zheng, V Thongboonkerd, M Xu, WM Pierce Jr, JB Klein, ... American Journal of Physiology-Endocrinology and Metabolism 287 (5), E896-E905, 2004 | 320 | 2004 |
| Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future DM Good, V Thongboonkerd, J Novak, JL Bascands, JP Schanstra, ... Journal of proteome research 6 (12), 4549-4555, 2007 | 311 | 2007 |
| Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles U Erdbrügger, CJ Blijdorp, IV Bijnsdorp, FE Borràs, D Burger, B Bussolati, ... Journal of extracellular vesicles 10 (7), e12093, 2021 | 290 | 2021 |
| Renal and urinary proteomics: current applications and challenges V Thongboonkerd, P Malasit Proteomics 5 (4), 1033-1042, 2005 | 286 | 2005 |
| Practical points in urinary proteomics V Thongboonkerd Journal of proteome research 6 (10), 3881-3890, 2007 | 261 | 2007 |
| Systematic comparisons of artificial urine formulas for in vitro cellular study S Chutipongtanate, V Thongboonkerd Analytical biochemistry 402 (1), 110-112, 2010 | 209 | 2010 |
| Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability V Thongboonkerd, S Chutipongtanate, R Kanlaya Journal of proteome research 5 (1), 183-191, 2006 | 197 | 2006 |
| Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain HF Poon, A Castegna, SA Farr, V Thongboonkerd, BC Lynn, WA Banks, ... Neuroscience 126 (4), 915-926, 2004 | 189 | 2004 |
| Implementation of proteomic biomarkers: making it work H Mischak, JPA Ioannidis, A Argiles, TK Attwood, E Bongcam‐Rudloff, ... European journal of clinical investigation 42 (9), 1027-1036, 2012 | 182 | 2012 |
| Human Proteinpedia enables sharing of human protein data S Mathivanan, M Ahmed, NG Ahn, H Alexandre, R Amanchy, PC Andrews, ... Nature biotechnology 26 (2), 164-167, 2008 | 180 | 2008 |
| Factors determining types and morphologies of calcium oxalate crystals: molar concentrations, buffering, pH, stirring and temperature V Thongboonkerd, T Semangoen, S Chutipongtanate Clinica chimica acta 367 (1-2), 120-131, 2006 | 163 | 2006 |
| Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice—a model of familial amyotrophic lateral sclerosis HF Poon, K Hensley, V Thongboonkerd, ML Merchant, BC Lynn, ... Free Radical Biology and Medicine 39 (4), 453-462, 2005 | 162 | 2005 |
